Suzuken's Business Growth Prospects Appear Good

Dow Jones10-19 13:47

0547 GMT - Suzuken's business growth prospects appear good, Nomura's Kyoichiro Shigemura says in a research report. Drivers include expected stable margins and increase in exclusive distribution contracts for specialty pharmaceuticals in prescription pharmaceuticals wholesaling operations, the analyst says. Others are expansion in digital services and linkage between manufacturer distribution and wholesale distribution. Nomura likes the Japanese pharmaceutical wholesaler's approach to anticipating investor expectations by undertaking reform in wholesaling business, formulating strategies to boost return on equity, and enhancing shareholder returns. The brokerage upgrades the stock's rating to buy from neutral and raises its target price to 3,550 yen from 2,785 yen. Shares are 2.8% higher at 2,778.5 yen.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment